Virtu Financial LLC Precipio, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.33 - $0.7 $603 - $1,279	1,828 Added 12.71%	16,215 $6,000
Q1 2023 May 01, 2023	SELL	$0.6 - $1.0 $18,455 - $30,759	-30,759 Reduced 68.13%	14,387 $10,000
Q4 2022 Feb 15, 2023	BUY	$0.5 - $17.4 $22,573 - $785,540	45,146 New	45,146 $25,000
Q1 2022 May 17, 2022	SELL	$1.19 - $1.71 $22,790 - $32,749	-19,152 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$1.58 - $2.77 $15,754 - $27,619	-9,971 Reduced 34.24%	19,152 $30,000
Q3 2021 Nov 12, 2021	SELL	$2.78 - $3.63 $41,936 - $54,758	-15,085 Reduced 34.12%	29,123 $82,000
Q2 2021 Sep 17, 2021	BUY	$1.8 - $5.25 $79,574 - $232,092	44,208 New	44,208 $160,000
Q4 2019 Feb 04, 2020	SELL	$1.81 - $2.6 $37,917 - $54,467	-20,949 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$2.18 - $4.08 $45,668 - $85,471	20,949 New	20,949 $55,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.